This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Safety and pharmacokinetics of EP-104IAR (sustained-release fluticasone propionate) in knee osteoarthritis: A randomized, double-blind, placebo-controlled phase 1 trial.
Osteoarthritis and cartilage open · 2021 · first author
Pharmacokinetic Profile of Intra-articular Fluticasone Propionate Microparticles in Beagle Dog Knees.
Cartilage · 2019
Latest funding
- $524,026
Validation and commercialization of an innovative analgesic for chronic pain
CIHR · 2019 · Principal investigator
2 publications.
Safety and pharmacokinetics of EP-104IAR (sustained-release fluticasone propionate) in knee osteoarthritis: A randomized, double-blind, placebo-controlled phase 1 trial.
Malone A, Price J, Price N, Peck V, Getgood A, Petrella R, Helliwell J
Pharmacokinetic Profile of Intra-articular Fluticasone Propionate Microparticles in Beagle Dog Knees.
Getgood A, Dhollander A, Malone A, Price J, Helliwell J
Validation and commercialization of an innovative analgesic for chronic pain
Principal investigators: Li, Shyh-Dar; Cairns, Brian E; Malone, Amanda
Keywords: Analgesic; Chronic Pain; Drug Validation And Commercialization; Opioid Crisis
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.